Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03093870
Title Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aslan Pharmaceuticals
Age Groups: child | adult | senior
Covered Countries USA | ESP | AUS

No variant requirements are available.